Tranche 1 and 2 $7m capital raising from some of the most sophisticated biotech institutional investors in Australia completed . Current share price of 8.6c is a bargain imo considering the clinical-stage pipeline with three Phase 1b/2 clinical trials in breast cancer, ovarian cancer and acute myeloid leukemia (AML) at prestigious US medical institutions.
Remaining $3.4m raising from rights issue expected to be filled next week. Will be taking up my lot and some extra's.
Tranche 1 and 2 $7m capital raising from some of the most...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
